Walleye Trading
PACB icon

Walleye Trading’s Pacific Biosciences PACB Stock Holding History

Walleye Trading’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,535
Closed -$63.2K – 4549
2024
Q4 		$63.2K Sell
34,535
-224
-0.6% -$437 ﹤0.01% 3726
2024
Q3 		$59.1K Buy
34,759
+10,382
+43% +$17.1K ﹤0.01% 3483
2024
Q2 		$33.4K Buy
+24,377
New +$49.2K ﹤0.01% 3686
2023
Q1 		– Sell
-16,657
Closed -$166K – 5239
2022
Q4 		$136K Buy
+16,657
New +$144K ﹤0.01% 3815
2022
Q1 		– Sell
-788
Closed -$9.07K – 5770
2021
Q4 		$16K Buy
+788
New +$19K ﹤0.01% 4990
2021
Q2 		– Sell
-19,081
Closed -$555K – 5441
2021
Q1 		$636K Buy
19,081
+18,154
+1,958% +$635K ﹤0.01% 2376
2020
Q4 		$24K Sell
927
-6,385
-87% -$109K ﹤0.01% 4356
2020
Q3 		$72K Sell
7,312
-13,682
-65% -$78.8K ﹤0.01% 3511
2020
Q2 		$72K Buy
+20,994
New +$71.5K ﹤0.01% 3669
2019
Q4 		– Sell
-95,297
Closed -$492K – 4501
2019
Q3 		$492K Sell
95,297
-5,196
-5% -$29.1K ﹤0.01% 2163
2019
Q2 		$608K Sell
100,493
-189,376
-65% -$1.33M 0.01% 2034
2019
Q1 		$2.1M Buy
289,869
+62,496
+27% +$452K 0.02% 1037
2018
Q4 		$1.68M Buy
227,373
+223,439
+5,680% +$1.42M 0.01% 1209
2018
Q3 		$21K Buy
+3,934
New +$16.9K ﹤0.01% 4830
2018
Q2 		– Sell
-66,000
Closed -$135K – 4807
2018
Q1 		$135K Buy
66,000
+41,718
+172% +$108K ﹤0.01% 3750
2017
Q4 		$64K Buy
+24,282
New +$85K ﹤0.01% 3956
2017
Q3 		– Sell
-85,319
Closed -$304K – 4475
2017
Q2 		$304K Buy
85,319
+69,075
+425% +$279K ﹤0.01% 2794
2017
Q1 		$84K Sell
16,244
-5,076
-24% -$24.8K ﹤0.01% 3508
2016
Q4 		$81K Buy
21,320
+16,344
+328% +$119K ﹤0.01% 3374
2016
Q3 		$45K Sell
4,976
-2,300
-32% -$19.2K ﹤0.01% 3824
2016
Q2 		$51K Buy
7,276
+5,947
+447% +$54.3K ﹤0.01% 3963
2016
Q1 		$11K Buy
+1,329
New +$13.1K ﹤0.01% 4704

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Walleye Trading's PACB Position: Q1 2025 in Review

Walleye Trading sold out of Pacific Biosciences (PACB) in Q1 2025, closing a stake of 34,535 shares — an estimated $63.2K sold.

Walleye Trading first reported a position in PACB in Q1 2016 and held it in 22 quarters. The position peaked at $2.1M in Q1 2019. 225 funds tracked by Wall St. Rank hold PACB as of Q1 2025.

  • Walleye Trading reported no remaining Pacific Biosciences position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 34,535 Pacific Biosciences shares in Q1 2025, an estimated $63.2K.
  • Walleye Trading first reported a position in Pacific Biosciences in Q1 2016 and held it in 22 quarters.
  • Walleye Trading's Pacific Biosciences position peaked at $2.1M in Q1 2019.
  • 225 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.